Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
10.1093/annonc/mdg118
Saved in:
Main Authors: | Millward, M.J., Boyer, M.J., Lehnert, M., Clarke, S., Rischin, D., Goh, B.-C., Wong, J., McNeil, E., Bishop, J.F. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/129612 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Cutaneous reaction associated with weekly docetaxel administration
by: Chew, L., et al.
Published: (2014) -
Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy
by: Soo, R.A., et al.
Published: (2014) -
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers
by: Yong, W.-P., et al.
Published: (2014) -
Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group study
by: Soo, R.A., et al.
Published: (2014) -
Docetaxel Pharmacogenetics and its Influence on the Pharmacokinetics/Pharmacodynamics of Docetaxel in Asian Nasopharyngeal Cancer Patients
by: CHEW SIN CHI
Published: (2013)